Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
17d

Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to ...

Detailed price information for Maze Therapeutics Inc (MAZE-Q) from The Globe and Mail including charting and trades.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now

Lets Trump withhold aid
Named in new Epstein docs
USDA issues alert
Smartmatic wins lawsuit
Thousands join Berlin protest
Dead man linked to 1991 case
Stampede in India
Shooting, fire at MI church
Agents fired over protest
Drops out of mayor’s race
Earhart files to be released
Truck driver rules tightened
To send troops to Portland
Superintendent arrested by ICE
NC waterfront bar shooting
Drone, missile attack on Kyiv
US to revoke Petro's visa
Earthquake hits Turkey
Reimposes sanctions on Iran
Two migrant women die
Vietnam evacuates thousands
Torrential flooding hits AZ
Russell M. Nelson dies
Moldovans cast ballots
To meet congressional leaders
Defamation suit settled
Fred Warner fined by NFL
Clears concussion protocol
Lynx coach Reeve suspended
Tropical Storm Imelda forms
Placed on IL w/ rib injury
Airstrikes, shooting in Gaza
Abrego Garcia transferred
Feedback
  • Privacy
  • Terms